Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings.

Literature DB >> 2839998

Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings.

E Hollander¹, M Fay, B Cohen, R Campeas, J M Gorman, M R Liebowitz.

Abstract

Six of eight patients with obsessive-compulsive disorder had an exacerbation of symptoms when given m-chlorophenylpiperazine. Fenfluramine and placebo produced mild improvement. Six patients given intravenous clonidine experienced marked reduction in obsessions. Implications for serotonergic and noradrenergic hypotheses of obsessive-compulsive disorder are discussed.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1988 PMID： 2839998 DOI： 10.1176/ajp.145.8.1015

Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112

Keyword Cloud
Cited

12 in total

1. Inhibitory Control in Pediatric Trichotillomania (Hair Pulling Disorder): The Importance of Controlling for Age and Symptoms of Inattention and Hyperactivity.

Authors: Elle Brennan; Sarah Francazio; John Gunstad; Christopher Flessner
Journal: Child Psychiatry Hum Dev Date: 2016-04

2. Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency.

Authors: Ulrich Voderholzer; Dieter Riemann; Christine Huwig-Poppe; Anne Katrin Kuelz; Andreas Kordon; Katharina Bruestle; Mathias Berger; Fritz Hohagen
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2006-12-05 Impact factor: 5.270

Review 3. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors: L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal: Drug Saf Date: 1996-08 Impact factor: 5.606

4. Lust, attraction, and attachment in mammalian reproduction.

Authors: H E Fisher
Journal: Hum Nat Date: 1998-03

5. Obsessive compulsive neurosis : clomipramine, prolactin and therapeutic response.

Authors: J Ananth; A Kaur; R Poland; M Wohl
Journal: Indian J Psychiatry Date: 1997-04 Impact factor: 1.759

6. Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

Authors: G A Ricaurte; U D McCann
Journal: Neurotox Res Date: 2001-01 Impact factor: 3.911

Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings.

1. Inhibitory Control in Pediatric Trichotillomania (Hair Pulling Disorder): The Importance of Controlling for Age and Symptoms of Inattention and Hyperactivity.

2. Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency.

Review 3. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

4. Lust, attraction, and attachment in mammalian reproduction.

5. Obsessive compulsive neurosis : clomipramine, prolactin and therapeutic response.

6. Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

7. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects.

8. 5-HT1A receptor-effector system responsivity in panic disorder.

Review 9. Theoretical and therapeutic considerations for the anxiety disorders.

10. Acute hormonal changes after IV citalopram and treatment response in OCD.